emjreviews.com20h
Spotlight: January 2025
Catch up on January’s top pharma news, from major industry deals and cutting-edge medical innovations to advancements in ...
Next-generation Sequencing (NGS) Market to Hit USD 22.38 Billion by 2029 with 11.0% CAGR | MarketsandMarkets
The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$ 13.28 ...
Next-generation Sequencing (NGS) Market to Hit USD 22.38 Billion by 2029 with 11.0% CAGR | MarketsandMarkets™
The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...
Daily1d
Merck WELIREG gets USFDA priority review for Advanced Pheochromocytoma and Paraganglioma
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA ...
Bleeding Disorders Treatment Market Projected To Reach USD 35.17 Billion By 2032, Growing At A Robust CAGR Of 8.91%
Driven by Biopharmaceutical Innovations and Gene Therapies, the market Booms Amidst Growing Incidence of Hemophilia and Von Willebrand Disease ...
$13.8 Bn Cellular Starting Materials Market by Product, Grade, End-User, and Region - Global Forecasts 2025-2035
The "Cellular Starting Materials Market by Product, by Grade, by End-User, and By Region" report has been added to ...